| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.30B | +2.7% |
| R&D Expense | $62.0M | -19.5% |
| SG&A Expense | $521.0M | -10.9% |
| Operating Income | $437.0M | +61.3% |
| Pre-tax Income | $125.0M | +16.8% |
| Income Tax | $44.0M | -81.6% |
| Net Income | $80.0M | +159.7% |
| EPS (Basic) | $1.11 | +158.4% |
| EPS (Diluted) | $1.08 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $419.0M | +23.6% |
| Accounts Receivable | $581.0M | -18.6% |
| Inventory | $307.0M | -7.8% |
| Current Assets | $1.75B | -7.7% |
| Total Assets | $5.54B | -3.6% |
| Current Liabilities | $1.72B | -1.4% |
| Long-term Debt | $2.99B | -3.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $344.0M | -3.1% |
| Capital Expenditures | $87.0M | -19.4% |
| Investing Cash Flow | -$135.0M | +57.3% |
| Financing Cash Flow | -$134.0M | -532.3% |
| Free Cash Flow | $257.0M | +4.0% |
| +156.8% |
| Total Liabilities |
| $5.31B |
| -2.6% |
| Stockholders' Equity | $219.0M | -22.9% |